ATRA vs JNJ: Which Stock is Better?
Side-by-side comparison of Atara Biotherapeutics Inc and Johnson & Johnson in 2026
ATRA
Atara Biotherapeutics Inc
—
JNJ
Johnson & Johnson
$248.82
Key Metrics Comparison
| Metric | ATRA | JNJ | Winner |
|---|---|---|---|
| Market Cap | $87.13M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze ATRA
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ATRA or JNJ a better investment?
Comparing ATRA and JNJ: Atara Biotherapeutics Inc has a market cap of $87.13M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ATRA and JNJ?
ATRA (Atara Biotherapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ATRA or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ATRA or JNJ?
Both ATRA and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: ATRA or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: ATRA or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $87.13M for ATRA.
Should I buy ATRA or JNJ in 2026?
Both ATRA and JNJ have investment merit. ATRA trades at $N/A while JNJ trades at $248.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ATRA and JNJ stock?
Key differences: Market Cap ($87.13M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy ATRA or JNJ in 2026?
The choice between ATRA and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ATRA and JNJ?
ATRA (Atara Biotherapeutics Inc) has a market cap of $87.13M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.